Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1989-6-8
|
pubmed:abstractText |
A retrospective study of 56 patients (23 primary and 36 relapsing) with superficial vesical carcinoma and treated with transurethral resection and directed chemoprophylaxis was done. Directed chemoprophylaxis is define as a specific type of adjuvant therapy where the drug is determined by a previous study with multivariant analysis of the relapse risk factors of a group of 385 cases, where the chemotherapeutic agent was also a variable. The drug is specified by the data introduced in a microprocessor program. Such chemoprophylactic approach has achieved a marked reduction in the relapse rate and increased the disease-free interval from 8 to 3 and from 70 to 83.5 respectively, with regard to the free drug choice approach.
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0210-4806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2496584-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2496584-Cisplatin,
pubmed-meshheading:2496584-Doxorubicin,
pubmed-meshheading:2496584-Drug Therapy, Computer-Assisted,
pubmed-meshheading:2496584-Humans,
pubmed-meshheading:2496584-Neoplasm Recurrence, Local,
pubmed-meshheading:2496584-Prospective Studies,
pubmed-meshheading:2496584-Random Allocation,
pubmed-meshheading:2496584-Risk Factors,
pubmed-meshheading:2496584-Thiotepa,
pubmed-meshheading:2496584-Urinary Bladder Neoplasms
|
pubmed:articleTitle |
[Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
|
pubmed:publicationType |
Journal Article,
English Abstract
|